If the international application discloses one or more nucleotide and/or amino acid sequences, it must contain a sequence listing, which is to be drawn up in compliance with the standard prescribed in Annex C of the Administrative Instructions under the PCT and published on the WIPO website. More specifically, the sequence listing must comply with the version of WIPO Standard ST.25 which is applicable on the date on which the sequence listing is submitted.[ 22 ]
Tables related to sequence listings must be included as an integral part of the description in the same format as the remainder of the application. Any pages of tables relating to sequence listings count as regular pages of the description for which full page fees are payable (see point 176).
The EPO accepts sequence listings filed on electronic media as specified by the EPO (see point 55).
If an international application is filed in electronic form, a sequence listing forming part of such application and filed in text format in compliance with Annex C is not taken into account for calculating the (page fee part of the) international filing fee (see point 176). There will be no need to file a second copy for the purposes of international search and, where applicable, international preliminary examination (see points 263, 393).
If any other option for filing a sequence listing is chosen, e.g. filing on paper or in image format, the sum of the page fee part of the international filing fee is calculated taking into account each page of the sequence listing. Furthermore, if the EPO is selected as ISA, SISA and/or IPEA a sequence listing in electronic form in text format in compliance with Annex C will be required (see points 263 ff).
Date retrieved: 30 December 2018